We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Rep. Henry Waxman (D-Calif.) is encouraging federal officials to purchase more generic HIV treatments for the President's Emergency Plan for AIDS Relief (PEPFAR). Read More
The FDA released a white paper saying it has the ability to approve follow-on biologics without extensive clinical trials, although some trials would be necessary for the follow-ons to replace original products. Read More
Wyeth's intravenous antibiotic Zosyn has reached blockbuster status despite not having patent protection, the company announced during its first-quarter earnings call. Read More